849 related articles for article (PubMed ID: 16981945)
1. Use of topical misoprostol to reduce radiation-induced mucositis: results of a randomized, double-blind, placebo-controlled trial.
Veness MJ; Foroudi F; Gebski V; Timms I; Sathiyaseelan Y; Cakir B; Tiver KW
Australas Radiol; 2006 Oct; 50(5):468-74. PubMed ID: 16981945
[TBL] [Abstract][Full Text] [Related]
2. The impact of concurrent granulocyte macrophage-colony stimulating factor on radiation-induced mucositis in head and neck cancer patients: a double-blind placebo-controlled prospective phase III study by Radiation Therapy Oncology Group 9901.
Ryu JK; Swann S; LeVeque F; Scarantino CW; Johnson D; Chen A; Fortin A; Pollock J; Kim H; Ang KK
Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):643-50. PubMed ID: 17293228
[TBL] [Abstract][Full Text] [Related]
3. Phase II double-blind randomized study comparing oral aloe vera versus placebo to prevent radiation-related mucositis in patients with head-and-neck neoplasms.
Su CK; Mehta V; Ravikumar L; Shah R; Pinto H; Halpern J; Koong A; Goffinet D; Le QT
Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):171-7. PubMed ID: 15337553
[TBL] [Abstract][Full Text] [Related]
4. Protective effect of alpha-tocopherol in head and neck cancer radiation-induced mucositis: a double-blind randomized trial.
Ferreira PR; Fleck JF; Diehl A; Barletta D; Braga-Filho A; Barletta A; Ilha L
Head Neck; 2004 Apr; 26(4):313-21. PubMed ID: 15054734
[TBL] [Abstract][Full Text] [Related]
5. Phase II clinical trial of local use of GM-CSF for prevention and treatment of chemotherapy- and concomitant chemoradiotherapy-induced severe oral mucositis in advanced head and neck cancer patients: an evaluation of effectiveness, safety and costs.
Mantovani G; Massa E; Astara G; Murgia V; Gramignano G; Lusso MR; Camboni P; Ferreli L; Mocci M; Perboni S; Mura L; Madeddu C; Macciò A
Oncol Rep; 2003; 10(1):197-206. PubMed ID: 12469169
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic effect of recombinant human epidermal growth factor (RhEGF) on mucositis in patients undergoing radiotherapy, with or without chemotherapy, for head and neck cancer: a double-blind placebo-controlled prospective phase 2 multi-institutional clinical trial.
Wu HG; Song SY; Kim YS; Oh YT; Lee CG; Keum KC; Ahn YC; Lee SW
Cancer; 2009 Aug; 115(16):3699-708. PubMed ID: 19514089
[TBL] [Abstract][Full Text] [Related]
7. Oral mucositis prevention by low-level laser therapy in head-and-neck cancer patients undergoing concurrent chemoradiotherapy: a phase III randomized study.
Gouvêa de Lima A; Villar RC; de Castro G; Antequera R; Gil E; Rosalmeida MC; Federico MH; Snitcovsky IM
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):270-5. PubMed ID: 21163585
[TBL] [Abstract][Full Text] [Related]
8. Comparison of toxicity associated with early morning versus late afternoon radiotherapy in patients with head-and-neck cancer: a prospective randomized trial of the National Cancer Institute of Canada Clinical Trials Group (HN3).
Bjarnason GA; Mackenzie RG; Nabid A; Hodson ID; El-Sayed S; Grimard L; Brundage M; Wright J; Hay J; Ganguly P; Leong C; Wilson J; Jordan RC; Walker M; Tu D; Parulekar W;
Int J Radiat Oncol Biol Phys; 2009 Jan; 73(1):166-72. PubMed ID: 18805649
[TBL] [Abstract][Full Text] [Related]
9. Palifermin decreases severe oral mucositis of patients undergoing postoperative radiochemotherapy for head and neck cancer: a randomized, placebo-controlled trial.
Henke M; Alfonsi M; Foa P; Giralt J; Bardet E; Cerezo L; Salzwimmer M; Lizambri R; Emmerson L; Chen MG; Berger D
J Clin Oncol; 2011 Jul; 29(20):2815-20. PubMed ID: 21670447
[TBL] [Abstract][Full Text] [Related]
10. Benzydamine for prophylaxis of radiation-induced oral mucositis in head and neck cancers: a double-blind placebo-controlled randomized clinical trial.
Kazemian A; Kamian S; Aghili M; Hashemi FA; Haddad P
Eur J Cancer Care (Engl); 2009 Mar; 18(2):174-8. PubMed ID: 19267733
[TBL] [Abstract][Full Text] [Related]
11. A double-blind, placebo-controlled, randomised trial of active manuka honey and standard oral care for radiation-induced oral mucositis.
Bardy J; Molassiotis A; Ryder WD; Mais K; Sykes A; Yap B; Lee L; Kaczmarski E; Slevin N
Br J Oral Maxillofac Surg; 2012 Apr; 50(3):221-6. PubMed ID: 21636188
[TBL] [Abstract][Full Text] [Related]
12. Effect of pilocarpine during radiation therapy: results of RTOG 97-09, a phase III randomized study in head and neck cancer patients.
Scarantino C; LeVeque F; Swann RS; White R; Schulsinger A; Hodson DI; Meredith R; Foote R; Brachman D; Lee N
J Support Oncol; 2006 May; 4(5):252-8. PubMed ID: 16724649
[TBL] [Abstract][Full Text] [Related]
13. Filgrastim (r-metHuG-CSF) and its potential use in the reduction of radiation-induced oropharyngeal mucositis: an interim look at a randomized, double-blind, placebo-controlled trial.
Schneider SB; Nishimura RD; Zimmerman RP; Tran L; Shiplacoff J; Tormey M; Contreras R; Juillard GF
Cytokines Cell Mol Ther; 1999 Sep; 5(3):175-80. PubMed ID: 10641576
[TBL] [Abstract][Full Text] [Related]
14. Laser phototherapy as topical prophylaxis against head and neck cancer radiotherapy-induced oral mucositis: comparison between low and high/low power lasers.
Simões A; Eduardo FP; Luiz AC; Campos L; Sá PH; Cristófaro M; Marques MM; Eduardo CP
Lasers Surg Med; 2009 Apr; 41(4):264-70. PubMed ID: 19347940
[TBL] [Abstract][Full Text] [Related]
15. Quality of life, mucositis, and xerostomia from radiotherapy for head and neck cancers: a report from the NCIC CTG HN2 randomized trial of an antimicrobial lozenge to prevent mucositis.
Duncan GG; Epstein JB; Tu D; El Sayed S; Bezjak A; Ottaway J; Pater J;
Head Neck; 2005 May; 27(5):421-8. PubMed ID: 15782422
[TBL] [Abstract][Full Text] [Related]
16. Intravenous amifostine during chemoradiotherapy for head-and-neck cancer: a randomized placebo-controlled phase III study.
Buentzel J; Micke O; Adamietz IA; Monnier A; Glatzel M; de Vries A
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(3):684-91. PubMed ID: 16243440
[TBL] [Abstract][Full Text] [Related]
17. [Immunoglobulin for prevention of radiogenic mucositis].
Mose S; Adamietz IA; Thilmann C; Saran F; Heyd R; Knecht R; Böttcher HD
HNO; 1995 Jul; 43(7):421-6. PubMed ID: 7672999
[TBL] [Abstract][Full Text] [Related]
18. Honey as topical prophylaxis against radiochemotherapy-induced mucositis in head and neck cancer.
Rashad UM; Al-Gezawy SM; El-Gezawy E; Azzaz AN
J Laryngol Otol; 2009 Feb; 123(2):223-8. PubMed ID: 18485252
[TBL] [Abstract][Full Text] [Related]
19. A randomized double-blind, placebo-controlled trial of zinc sulfate supplementation for alleviation of radiation-induced oral mucositis and pharyngitis in head and neck cancer patients.
Sangthawan D; Phungrassami T; Sinkitjarurnchai W
J Med Assoc Thai; 2013 Jan; 96(1):69-76. PubMed ID: 23720981
[TBL] [Abstract][Full Text] [Related]
20. The effect of topical application of pure honey on radiation-induced mucositis: a randomized clinical trial.
Motallebnejad M; Akram S; Moghadamnia A; Moulana Z; Omidi S
J Contemp Dent Pract; 2008 Mar; 9(3):40-7. PubMed ID: 18335118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
